Title:
Coronavirus/Pandemic Vaccine/Treatment Manufacturing Capacity
Agreement Value:
$199,159,000.00
Agreement Date:
Nov 20, 2020 - Mar 31, 2024
Description:
This project will help develop Canada's medical countermeasures to COVID-19 and future pandemics by expanding RBI's manufacturing capabilities to create additional vaccine, therapy and fill/finish capacity at its Mississauga, Ontario site.
Organization:
Innovation, Science and Economic Development Canada
Expected Results:
This project will help develop Canada's medical countermeasures to COVID-19 and future pandemics by expanding RBI's manufacturing capabilities to create additional vaccine, therapy and fill/finish capacity and build Canada's long term emergency preparedness. This project will create 40 new full-time positions.
Location:
Mississauga, Ontario, CA L5N8H9
Reference Number:
033-2021-2022-Q1-816022
Agreement Type:
Other transfer payment
Report Type:
Grants and Contributions
Recipient Business Number:
720950070
Recipient Type:
For-profit organization
Additional Information:
This is a partially repayable contribution
Recipient's Operating Name:
Resilience Biotechnologies Inc.
Recipient's Legal Name:
Resilience Biotechnologies Inc.
Federal Riding Name:
Mississauga--Streetsville
Federal Riding Number:
35063
Program:
SIF Stream2- Growth
Program Purpose:
-Encourage R&D that will accelerate technology transfer and commercialization of innovative products, processes and services;-Facilitate the growth and expansion of firms in Canada;-Attract and retain large scale investments to Canada; and-Advance industrial research, development and technology demonstration through collaboration between academia, non-profit organizations and the private sector.